Shintaro Shirahama, MD, PhD Schepens Eye Research Institute Harvard Medical School PROJECT TITLE: Development of a novel transplant-independent therapy for retinal pigment epithelium (RPE) dysfunction using epigenetic reprogramming of RPE stem cells Dr. Shirahama has a strong background in ocular inflammatory diseases, including infectious and non-infectious uveitis. After graduating from medical school in Japan, Dr. […]
Read More
JAMES WALSH, MD, PhD PROJECT TITLE: The choroidal adaptive immune system is vital in the pathogenesis of retinal inflammation James Walsh, MD, PhD, specializing in ophthalmology and uveitis, is a clinician-scientist at Washington University in St. Louis, Missouri. He is currently working on a project with the potential to be transformative in the understanding of […]
Read More
So Goto, MD, PhD University of California Berkeley School of Optometry So Goto, MD, PhD, has been selected as the 2022 Loris and David Rich Postdoctoral Scholar for his project, Role of retinal pigment epithelium in choroidal thickness modulation and myopia maculopathy. After receiving a Bachelor of Medicine (MD) from Kanazawa University School of Medicine […]
Read MoreCynthia Toth, MD, Joseph A.C. Wadsworth Professor of Ophthalmology, has been appointed Vice Chair for Clinical Research, at Duke University Eye Center in Durham, North Carolina. Dr. Toth specializes in the evaluation and surgical treatment of vitreoretinal diseases in infants, children, and adults, and in novel research resulting in the clinical application of optical coherence […]
Read More